According to a major Department of Defense (DoD) study, the vast majority of Covid-19 hospitalizations of medicare recipients (65 and older) are fully vaccinated. The study also highlights that prior Covid-19 infection has a major protective effect against breakthrough hospitalization from the SARS-Cov-2 Delta variant.
This study, which was conducted by HuMetrix and designated as Project Salus, contradicts the mainstream arguments that natural immunity developed from a prior Covid-19 infection is not sufficient to protect people. Natural immunity from prior infection now appears to be superior to the immunity offered by the Pfizer and Moderna vaccines in people 65 years and older.
Count this as another win for natural immunity and a blow to mainstream Covid-19 vaccine evangelism! Natural immunity has a superior protective effect in the fight against covid that should not be ignored. Vaccine mandates are not the answer.
HuMetrix, working on behalf of the DoD and Joint Artificial Intelligence Center (JAIC), performed a massive Covid-19 data analysis of 5.6 million medicare patients (2.7 million Pfizer and 2.9 million Moderna) to draw their conclusions. Interestingly, Project Salus also revealed that Covid-19 vaccine effectiveness (VE) wanes significantly over time.
Why am I not surprised? Could Antibody Dependent Enhancement (ADE) be lurking in the shadows?
Executive summary highlights from Project Salus:
▪ VE of both mRNA vaccines appears to wane overtime in this large 5.6M US-based 65 & over vaccinated cohort
▪ Risk of breakthrough hospitalization increases with time elapsed since mRNA vaccination with odds ratio increasing to 2.5 at 6 months post vaccination
▪ VE against Delta breakthrough hospitalization (62%) exceeds VE against Delta infection (41%)
▪ Prior COVID-19 infection has a major protective effect against breakthrough hospitalization
▪ Older age groups (75-84 & 85 and older) experienced further reduction in vaccine protection against hospitalization
▪ Hospitalization rate (21% vs 32%) and death rate (4% vs 12%) of breakthrough infections lower than rates observed in Covid-19 cases in pre-vaccination pandemic phase in 2020
According to this chart, people in the medicare analysis with prior Covid-19 infection have the lowest risk for a breakthrough (Delta variant) hospitalization.
Read the full analysis or download here: